eicosapentaenoic acid ethyl ester has been researched along with Respiratory Distress Syndrome in 2 studies
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dushianthan, A | 1 |
| Cusack, R | 1 |
| Burgess, VA | 1 |
| Grocott, MP | 1 |
| Calder, P | 1 |
| Langlois, PL | 1 |
| D'Aragon, F | 1 |
| Hardy, G | 1 |
| Manzanares, W | 1 |
2 reviews available for eicosapentaenoic acid ethyl ester and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis.
Topics: Antioxidants; Cause of Death; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Ent | 2020 |
Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis.
Topics: Antioxidants; Critical Illness; Eicosapentaenoic Acid; Enteral Nutrition; Fatty Acids, Omega-3; gamm | 2019 |